Cutting-Edge Wohl Institute for Translational Medicine is Inaugurated at Sheba
On October 16th, 2017, Professor Shlomo Noy, President of Tel Hashomer Medical Research, Infrastructure and Services Ltd., and Professor Gideon Rechavi, Director of the Sheba Cancer Research Center, together with a prestigious delegation from the Maurice and Vivienne Wohl Foundation, inaugurated the new Wohl Institute for Translational Medicine at Sheba Medical Center.
The Wohl Foundation, which is celebrating its 50th anniversary, was the philanthropic mover and shaker in establishing the unique translational medicine facility, based on the parameters the Foundation had set for medical centers to bid on the project.
The hospital’s outstanding synthesis between cutting-edge research and advanced technologies enabled Sheba to win the bid and utilize the $6.5 million dollar budget to create the Translational Medicine facility.
An emerging scientific discipline, translational medicine represents the bridge between fundamental research in laboratories and clinical research applied to the patient, converting promising discoveries into clinical applications and making sure that therapeutic innovations get to patients at a faster clip. This translates into more efficient medical care and improved health of patients across the board.
Creating cutting-edge labs in the fields of genetics, proteomics, bioinformatics and research, along with combining biological and the chemical applications, constitutes the first-stage of the Wohl Institute for Translational Medicine’s work. The second stage of the project is scheduled for 2018, when new sterile labs will enable the development of new medical treatments in the fields of cellular and genetic therapies, as well as tissue engineering.
The Wohl Institute for Translational Medicine is priming itself to accelerate research into such catastrophic maladies such as cancer, metabolic diseases, kidney diseases, neurological diseases, skin diseases, leukemia and genetic diseases.
Researchers and doctors at Sheba are already collaborating in the Wohl Institute for Translational Medicine, using the results of their initial research in order to accelerate the development of new diagnostic technologies that will foment new medical treatments.
Professor Shlomo Noy said, “The research standards and our internationally recognized expertise enables Sheba to convert scientific knowledge into practical medical solutions for patients. On the basis of those advances, Sheba will continue to cooperate with the academic world and the pharmaceuticals industry in order to enhance scientific progress.”
